Sagility is investment heavily in Ai and Automation, with 18 Live Ai Use Cases and 15+ in Development | Photo Credit: Gawrav

Target: ₹ 60

CMP: ₹ 46.48

Sagility India is a healthcare-focused bpm and digital transformation company with 25+ years of expertise, serving 77 ACTIVE CLINTS Including Leading Us Payers, Provides, Providers, Provors, PBMS, and Technology Platforms.

In Q1 FY26, Sagility Onboarded 4 New Clients, A $ 12B Regional Blues Plan, A $ 5B Specialty Health System, A Pharmacy Benefit Manager (PBM), and A Technology Tpa FIRM, WHILE Axpanding Business with 18 existing clients and sustaining long-term partnerships of 10–25 years. $ 32 M (Potential Steady State Accv) of New Business & Expantion Won in Q1 FY26

Sagility is investment heavily in AI and Automation, with 18 Live Ai Use Cases (EG, Nurse Assist, Appeals Assist, Contract Validation) and 15+ in Development, and have expanded capabilityes threadpathpathpathpathpathpathpathpaths, Birchai, and DCI Acquisitions.

We assign a boy rating on sagility with a target price of ₹ 60, derived from a 26 × p/e multiple on fy27e Eps. The rating reflects the company’s Deep Healthcare Domain Expertise, Long-Standing Client Relection, Rising Profitability, Strong Cash Generation, and its strategic focus on ai-led transformation, voice Togeether reinforce visibility of sustained growth and shareholder value creation.

Sagility’s Key Risks Include High Client Concentration, Us Healthcare Regulatory Changes, Elevated Attrition, Currency Fluctations, and A Goodwill-HEVY Balance Sheet from Acquishe Cold Affect Growth and Profitability.

Published on September 18, 2025